{"gene":"ITGAM","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1993,"finding":"CR3 (CD11b/CD18) functions both as an adhesion molecule and a phagocytic/cytotoxicity receptor with multiple ligand specificities, including iC3b, ICAM-1, bacterial carbohydrates/LPS, and soluble beta-glucan from yeast. Beta-glucan binding to CR3 induces an activated receptor state that permits neutrophil phagocytosis of iC3b-coated targets and NK cell cytotoxicity of iC3b-coated tumor cells that are normally resistant.","method":"Functional receptor binding assays, phagocytosis and cytotoxicity assays with beta-glucan and anti-CR3 antibodies","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays in a single review/research synthesis; replicated across phagocyte and NK cell contexts but methods described at abstract level","pmids":["8485905"],"is_preprint":false},{"year":1997,"finding":"Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein; binding occurs on both the αM (CD11b) and β2 (CD18) subunits. Soluble fibrinogen (a natural Mac-1 ligand) competes with oligodeoxynucleotide binding. Upregulation of Mac-1 surface expression increases oligodeoxynucleotide binding and internalization by PMNs. Mac-1-bound oligodeoxynucleotides inhibit β2-dependent migration through Matrigel while dramatically increasing reactive oxygen species production in PMNs adherent to fibrinogen.","method":"Competitive binding assays with fibrinogen, anti-Mac-1 monoclonal antibody blocking, surface expression upregulation, Matrigel migration assay, ROS production assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (competitive binding, antibody blocking, functional migration and ROS assays) in a single focused study","pmids":["9095175"],"is_preprint":false},{"year":1990,"finding":"Mac-1 (CD11b/CD18) is stored in gelatinase-rich (pre-gamma, secondary) granules of neutrophils and translocates to the plasma membrane upon chemotactic stimulation with FMLP. Neonatal neutrophils show diminished translocation of Mac-1 from these granular pools and reduced surface expression after FMLP stimulation, correlated with significantly lower gelatinase content, contributing to abnormal migratory properties.","method":"Subcellular fractionation, immunochemical assays, enzymatic gelatinase assays, surface expression measurement before and after FMLP stimulation comparing neonatal vs. adult neutrophils","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular fractionation with functional consequence (migration defect), multiple orthogonal biochemical methods","pmids":["2153038"],"is_preprint":false},{"year":1991,"finding":"The CD11b gene promoter region extending 242 bp upstream and 71 bp downstream of the transcription initiation site is sufficient to direct myeloid-specific and developmentally regulated expression in vitro, mimicking endogenous CD11b expression. A single transcription initiation site was identified, and the minimal promoter contains binding sites for transcription factors involved in hematopoietic-specific and phorbol ester-inducible gene expression.","method":"Promoter cloning, transcription start site mapping, promoter-reporter assays in cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter-reporter assay with defined minimal region, single lab","pmids":["1683702"],"is_preprint":false},{"year":1989,"finding":"CD11b/CD18 (Mo1) mRNA expression increases coordinately with cell surface protein expression during myeloid differentiation along both monocytic and granulocytic pathways in HL-60 cells, indicating regulation occurs at the mRNA level.","method":"Myeloid differentiation of HL-60 cells, mRNA quantification correlated with cell surface expression by flow cytometry","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mRNA and protein expression correlated across two differentiation pathways, single lab","pmids":["2562920"],"is_preprint":false},{"year":1999,"finding":"CD11b/CD18 activation in neutrophils is regulated by an oxidative S-thiolation mechanism downstream of tyrosine kinase signaling. Exogenously added H2O2 induces CD11b/CD18-dependent adhesion and expression of an integrin activation neoepitope (mAb clone 24). This activation is inhibited by tyrosine kinase inhibitors and by complexing sulfhydryl groups with PAO. TNF-alpha-triggered CD11b/CD18 activation is blocked by the flavoprotein oxidoreductase inhibitor DPI and free radical scavengers.","method":"Neutrophil adhesion assays, integrin activation neoepitope detection (mAb 24), pharmacological inhibitors of tyrosine kinases, sulfhydryl reagents, oxidase inhibitors, and comparison with integrin-activating antibody (KIM 185)","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro assay with mechanistic inhibitor dissection using multiple orthogonal pharmacological tools and activation-state-specific antibody","pmids":["10556796"],"is_preprint":false},{"year":2006,"finding":"Nitric oxide (NO) upregulates CD11b expression in microglial cells via the guanylate cyclase (GC)-cGMP-PKG-CREB signaling pathway. LPS-induced NO production increases CD11b expression; this is blocked by NO scavengers (PTIO) or iNOS inhibitors (L-NIL). The NO donor GSNO directly induces CD11b expression, and inhibitors of GC (NS2028) or PKG (KT5823, Rp-8-bromo-cGMP) block this upregulation, while 8-bromo-cGMP and cGMP phosphodiesterase inhibitor MY-5445 alone induce CD11b. GSNO-induced CREB activation via PKG was required.","method":"Pharmacological inhibitor/activator studies in BV-2 and primary microglial cells, NO donor treatment, in vivo co-microinjection experiments, flow cytometry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple pharmacological pathway dissections with both inhibitors and activators at each node, in vitro and in vivo validation","pmids":["16551637"],"is_preprint":false},{"year":2009,"finding":"Mac-1 (CD11b/CD18) on recruited neutrophils is a critical molecular link between inflammation and thrombosis in glomerulonephritis. Mac-1-deficient mice show markedly attenuated neutrophil recruitment, endothelial injury, glomerular thrombosis, and acute renal failure. Neutrophil elastase activity is reduced in Mac-1-deficient mice, implicating it as an effector of Mac-1-mediated injury. Mac-1 on neutrophils interacts with glycoprotein Ibα (GPIbα) on platelets; antibody-mediated disruption of this Mac-1–GPIbα interaction attenuates thrombotic glomerulonephritis without affecting renal neutrophil accumulation.","method":"Genetic knockout (Mac-1-deficient mice), neutrophil immunodepletion, platelet immunodepletion, antibody-mediated blockade of Mac-1–GPIbα interaction, enzymatic activity assays, histopathology","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus specific antibody blockade of defined molecular interaction (Mac-1–GPIbα) with clear functional readout, multiple orthogonal approaches","pmids":["19752320"],"is_preprint":false},{"year":2012,"finding":"The lupus-associated rs1143679 (R77H) variant of ITGAM (CD11b) impairs a broad range of CR3 effector functions in human monocytes, including: 31% reduction in phagocytosis of iC3b-opsonized erythrocytes, 24% reduction in adhesion to iC3b, and loss of CR3-ligation-mediated inhibition of TLR7/8-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α). The functional defect was confirmed by replication in COS7 cells transfected with variant-specific CD11b. No genotype-specific difference in CD11b expression or activation epitope expression was observed.","method":"Ex vivo monocytes/macrophages from homozygous WT or 77H donors; phagocytosis assay, adhesion assay, cytokine ELISA after CR3 ligation, conformation-specific antibody staining; COS7 cell transfection with variant-specific CD11b","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays in primary human cells plus independent validation in transfected cells; clear mechanistic separation of expression vs. function","pmids":["22586164"],"is_preprint":false},{"year":2013,"finding":"CD11b negatively regulates B cell receptor (BCR) signaling to maintain autoreactive B cell tolerance. CD11b-deficient autoreactive B cells show hyperproliferative BCR responses and enhanced survival. Mechanistically, CD11b directly binds CD22; in its absence, CD22-SHP-1 recruitment is diminished, leading to decreased Lyn and CD22 phosphorylation and increased calcium influx. The lupus-associated rs1143679 variant of CD11b completely abrogates this regulatory effect on BCR signaling through disruption of CD22-CD11b direct binding.","method":"Co-IP demonstrating CD22-CD11b direct binding, BCR crosslinking proliferation assay in CD11b-deficient vs. WT B cells, phosphotyrosine analysis, SHP-1 recruitment assay, calcium flux measurement, transfection of WT and rs1143679 variant CD11b, in vivo BCR engagement in CD11b-/- mice","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct binding shown by Co-IP, multiple orthogonal signaling assays, genetic KO, variant-specific functional rescue, in vivo validation","pmids":["24264377"],"is_preprint":false},{"year":2017,"finding":"CD11b activation suppresses TLR-dependent inflammatory signaling and type I interferon (IFN-I) responses in leukocytes via an AKT/FOXO3/IRF3/IRF7 pathway. Pharmacological activation of CD11b with small molecule agonist LA1 reduces IFN-I responses in WT but not CD11b-deficient mice and protects lupus-prone MRL/Lpr mice from end-organ injury. Three nonsynonymous ITGAM SNPs that reduce CD11b activity are associated with elevated IFN-I in lupus patients. TLR-stimulated macrophages from CD11B SNP carriers show increased basal IRF7 and IFN-β expression and increased nuclear exclusion of FOXO3, all suppressed by LA1.","method":"Small molecule CD11b agonist (LA1) treatment, CD11b-deficient mice, lupus-prone mouse model (MRL/Lpr), signaling pathway analysis (AKT/FOXO3/IRF3/7), macrophages from human ITGAM SNP carriers, flow cytometry, ELISA","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological activation plus genetic KO controls, pathway dissection across multiple levels, validated in both mouse models and human primary cells from SNP carriers","pmids":["28263189"],"is_preprint":false},{"year":2018,"finding":"CD11b activation promotes pro-inflammatory (M1) macrophage polarization by stimulating expression of microRNA Let-7a. Conversely, CD11b inhibition prevents Let-7a expression and induces cMyc expression, leading to immune-suppressive macrophage polarization, vascular maturation, and accelerated tumor growth. Pharmacological activation of CD11b with small molecule agonist Leukadherin 1 (LA1) promotes pro-inflammatory polarization and suppresses tumor growth. Unexpectedly, CD11b does not regulate myeloid cell recruitment to tumors but controls myeloid cell polarization.","method":"CD11b genetic knockout and pharmacological activation (LA1), myeloid cell polarization assays, microRNA expression analysis (Let-7a), cMyc expression measurement, tumor growth models (murine and human cancer xenografts)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus pharmacological activation with defined molecular intermediates (Let-7a, cMyc), multiple cancer models, unexpected negative finding on recruitment rigorously established","pmids":["30568188"],"is_preprint":false},{"year":2019,"finding":"The staphylococcal pore-forming cytotoxin leukocidin GH (LukGH) binds the α-I domain of CD11b with two binding interfaces (on LukG and LukH protomers). Human CD11b-I induces LukGH oligomerization in solution, which is required for cytolytic activity. LukGH binds murine CD11b-I weakly and is inactive toward murine neutrophils. A LukGH variant engineered to bind mouse CD11b-I demonstrated that cytolysis requires both binding and receptor-dependent oligomerization.","method":"Crystal structure of LukGH in complex with human and murine CD11b α-I domain, SAXS for oligomerization in solution, engineered LukGH variants with altered CD11b binding specificity, cytolysis assays with murine neutrophils","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus SAXS plus mutagenesis plus functional cytolysis assay; multiple orthogonal methods in one rigorous study","pmids":["31852826"],"is_preprint":false},{"year":2018,"finding":"Integrin CD11b negatively regulates Mincle-mediated macrophage inflammatory signaling via recruitment of a Lyn-SIRPα-SHP1 complex. Upon Mincle activation by mycobacterial cord factor, CD11b is activated and forms a Mincle-CD11b signaling complex. Activated CD11b recruits Lyn, SIRPα, and SHP1, which dephosphorylate Syk to inhibit downstream Mincle-mediated inflammation. CD11b deficiency results in hyperinflammation following mycobacterial infection.","method":"Co-immunoprecipitation of Mincle-CD11b complex, CD11b knockout macrophages, phosphorylation assays for Syk, Lyn activator (MLR1023) experiments, mycobacterial infection model","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP defining complex components, genetic KO phenotype, pharmacological Lyn activator validating pathway, multiple orthogonal methods","pmids":["29400702"],"is_preprint":false},{"year":2015,"finding":"The heteromeric transcription factor GABP (GABPα/GABPβ1) directly activates the ITGAM/CD11b promoter via three binding sites close to the translational start site, inducing CD11b expression and myeloid differentiation. Demonstrated by luciferase reporter assays, chromatin immunoprecipitation (ChIP), and Shield1-dependent proteotuning.","method":"Luciferase promoter reporter assays, chromatin immunoprecipitation (ChIP), Shield1-dependent protein-level tuning, surface marker and morphological analysis of myeloid differentiation, overexpression in U937 cells","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP plus reporter assay plus functional consequence (myeloid differentiation), three orthogonal methods, single lab","pmids":["26170143"],"is_preprint":false},{"year":2016,"finding":"Folate receptor β (FRβ) interacts with CD11b/CD18 at the plasma membrane of macrophages, impairing CD11b/CD18-mediated adhesion to collagen. FRβ(+) macrophages and FRβ-transduced THP-1 cells show reduced adhesion to collagen compared to FRβ(-) counterparts. FRβ is only expressed by human macrophages differentiated with M-CSF.","method":"Affinity purification and mass spectrometric analysis of FRβ protein microenvironment, cell adhesion assay to collagen, FRβ transduction of THP-1 cells, flow cytometry, primary human macrophage differentiation conditions","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — affinity purification/MS for interaction plus functional adhesion assay; single lab, two orthogonal methods","pmids":["27534550"],"is_preprint":false},{"year":2020,"finding":"CD11b signaling prevents chondrocyte hypertrophy and mineralization. CD11b-deficient chondrocytes show increased mineralization in vitro (quantified by Alizarin Red), elevated alkaline phosphatase (Alp) expression and activity, enhanced secretion of pro-mineralizing IL-6, and increased ratios of collagen X/collagen II and Runx2/Sox9 (indices of hypertrophy). Addition of anti-IL-6 receptor antibody to CD11b-KO chondrocytes reduces calcification, identifying IL-6 as a downstream mediator. CD11b agonist LA1 reduces chondrocyte mineralization, Alp expression, IL-6 production, and collagen X expression. In the meniscectomy OA model, CD11b deficiency leads to more severe OA.","method":"Primary murine CD11b KO chondrocytes, Alizarin Red staining for mineralization, qRT-PCR for gene expression, Alp activity assay, ELISA for IL-6, anti-IL-6R antibody blocking, CD11b agonist LA1, in vivo meniscectomy OA model with OARSI scoring","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus pharmacological rescue plus pathway blockade (anti-IL-6R) plus in vivo model; multiple orthogonal methods identifying IL-6 as mechanistic mediator","pmids":["33392201"],"is_preprint":false},{"year":2023,"finding":"Siglec-15 binds integrin CD11b on human T cells as a binding partner. This interaction was identified by co-crystallization and binding studies; Siglec-15 binding to T cells (which lack STn expression) depends on α(2,3)- and α(2,6)-linked sialoglycans and requires CD11b as the receptor.","method":"Crystal structure of Siglec-15, STD-NMR spectroscopy for binding mode characterization, molecular dynamics simulations, identification of CD11b as Siglec-15 binding partner on T cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus NMR plus molecular dynamics plus functional binding partner identification; single study with multiple orthogonal structural/biophysical methods","pmids":["37311743"],"is_preprint":false},{"year":2005,"finding":"CR3 (CD11b/CD18) serves as the receptor for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mediates phagocytosis of B. pertussis. FHA-mediated attachment to CR3 promotes phagocytosis. Anti-CR3 antibody blocks both attachment and phagocytosis. Elevated CR3 surface expression alone (induced by TNF-α, IFN-γ, FHA, or pertussis toxin) is not sufficient to promote phagocytosis; TNF-α increased both CR3 expression and phagocytic capacity, while IFN-γ increased expression without increasing phagocytosis. Adenylate cyclase toxin (ACT) resists phagocytosis independently of CR3 expression level.","method":"Anti-CR3 antibody blocking of attachment and phagocytosis, purified FHA/pertussis toxin/ACT treatments, CR3 surface expression measurement, phagocytosis assays with FHA mutants and SphB1 protease mutants","journal":"Infection and immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — antibody blockade plus bacterial mutant panel plus dissociation of expression vs. functional activation; mechanistic separation of ligand binding from phagocytic signaling","pmids":["16239529"],"is_preprint":false},{"year":2019,"finding":"Partial pharmacological activation of CD11b with small molecule agonist ADH-503 repolarizes tumor-associated macrophages, reduces immunosuppressive myeloid cell infiltration in pancreatic tumors, and enhances dendritic cell and antitumor T cell responses, rendering checkpoint inhibitors effective in previously unresponsive PDAC models.","method":"Small molecule CD11b agonist (ADH-503) in mouse PDAC models, flow cytometry for myeloid cell polarization and T cell responses, combination with checkpoint inhibitors","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological activation with defined agent in multiple tumor models, but mechanism of polarization not fully dissected at molecular level in abstract","pmids":["31270275"],"is_preprint":false},{"year":2017,"finding":"CD11b regulates the Treg/Th17 balance in murine arthritis via IL-6. CD11b-deficient dendritic cells produce much stronger IL-6 and induce enhanced Th17-cell differentiation compared to WT DCs. Anti-IL-6 receptor antibody treatment in CD11b-/- mice suppressed Th17 induction and reduced arthritis severity. Severe arthritis in CD11b-/- mice was rescued by adoptive transfer of CD11b+ DCs, placing CD11b upstream of IL-6-mediated Th17 differentiation.","method":"CD11b knockout mouse arthritis model (CIA), DC co-culture with T cells, IL-6 ELISA, anti-IL-6R antibody treatment, adoptive transfer of CD11b+ DCs","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus cytokine blockade plus adoptive transfer rescue; epistatic placement of CD11b upstream of IL-6/Th17 axis with multiple orthogonal approaches","pmids":["28191643"],"is_preprint":false},{"year":2020,"finding":"S100A8/A9 (alarmin) is required for upregulation of CD11b specifically on neutrophils during chronic tuberculosis infection, mediating neutrophil accumulation in the lung. S100A8/A9 deficiency results in reduced CD11b expression on neutrophils and impaired neutrophil accumulation, with improved Mycobacterium tuberculosis control during chronic (but not acute) TB.","method":"S100A8/A9-deficient mice, TB infection model, neutrophil depletion, flow cytometry for CD11b expression, comparison of acute vs. chronic TB","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic deficiency model with specific neutrophil CD11b phenotype; single lab, two orthogonal approaches (gene KO and neutrophil depletion)","pmids":["32134742"],"is_preprint":false},{"year":2014,"finding":"CD11b is the major complement receptor mediating macrophage adherence to helminth larval surfaces. In vitro coculture of bone marrow-derived macrophages with H. polygyrus bakeri larvae demonstrated that CD11b mediates complement-dependent MΦ adherence. However, larval immobilization was largely independent of CD11b and instead required FcγRI (CD64).","method":"In vitro coculture assay of larvae and bone marrow-derived MΦ, CD11b-deficient macrophages, antibody blocking, in vivo challenge infection","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus in vitro assay plus in vivo validation; mechanistic distinction between adherence (CD11b) and immobilization (FcγRI) functions established","pmids":["25548226"],"is_preprint":false},{"year":2020,"finding":"CD11b on myeloid cells mediates macrophage adhesion and migration to the vasculature during hypertension. CD11b knockout or anti-CD11b antibody treatment attenuates Ang II-induced hypertension, aortic remodeling, superoxide generation, vascular dysfunction, and CD11b+ macrophage infiltration. Wild-type mice reconstituted with CD11b-deficient bone marrow recapitulate these protective effects. Conversely, CD11b agonist LA1 exacerbates hypertensive response.","method":"CD11b KO mice, bone marrow chimeras, pharmacological CD11b inhibition (neutralizing antibody) and activation (LA1), Ang II and DOCA-salt hypertension models, macrophage adhesion and migration assays in vitro, flow cytometry, aortic ring analysis","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus bone marrow chimera plus pharmacological bidirectional modulation (inhibition and activation); multiple orthogonal approaches in two hypertension models","pmids":["36377602"],"is_preprint":false},{"year":2023,"finding":"CD11b mediates hypertensive cardiac remodeling by regulating macrophage infiltration and M1 polarization. CD11b and CD18 are the most highly upregulated integrin subunits in Ang II-infused hearts. CD11b KO or neutralizing antibody treatment attenuates cardiac remodeling and macrophage infiltration/M1 polarization. CD11b agonist LA1 shows opposite (worsening) effects. In vitro, CD11b KO reduces macrophage adhesion and M1 polarization, and reduces paracrine-induced cardiomyocyte enlargement and fibroblast differentiation.","method":"CD11b KO mice, bone marrow chimeras, anti-CD11b antibody and LA1 agonist, Ang II and DOCA-salt cardiac remodeling models, in vitro macrophage-cardiomyocyte co-cultures, flow cytometry, histology","journal":"Journal of advanced research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus bone marrow chimera plus pharmacological bidirectional modulation in two disease models; in vitro mechanistic dissection of adhesion and polarization","pmids":["36822392"],"is_preprint":false},{"year":2021,"finding":"CD11b and the mechanosensitive ion channel Piezo1 engage in crosstalk in macrophages responding to mechanical stretch. Both static and cyclic stretch increase CD11b expression and decrease Piezo1 expression. siRNA knockdown of CD11b abrogates stretch-mediated changes in inflammatory responses. Knockdown of CD11b enhances Piezo1 expression, and conversely knockdown of Piezo1 enhances CD11b expression, indicating reciprocal regulation. Stretch-mediated macrophage activation changes are dependent on actin polymerization.","method":"Static and cyclic uniaxial stretch apparatus, siRNA knockdown of CD11b and Piezo1, cytokine response assays (IFNγ/LPS and IL4/IL13 stimulation), actin polymerization inhibitor (pharmacological), flow cytometry for CD11b expression","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown of both interacting proteins with reciprocal phenotypes and functional readouts; single lab","pmids":["34630381"],"is_preprint":false},{"year":2020,"finding":"CD154 (CD40L) can bind CD11b as an alternate receptor during alloimmunity, distinct from the classical CD154-CD40 interaction. A peptide antagonist that specifically blocks CD154-CD11b interaction (without affecting CD154-CD40) significantly increased allograft survival when combined with anti-CD40 antibody, and reduced graft-infiltrating CD8+ T cells and innate immune cells. CD154-CD11b antagonism was more effective than CD40 blockade alone.","method":"Fully allogeneic murine transplant model, CD40-/- hosts, CD154-CD11b-specific peptide antagonist, antibody blockade of CD40, flow cytometry for graft-infiltrating cells","journal":"American journal of transplantation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — specific peptide antagonist for CD154-CD11b interaction (with CD40-independent controls) plus genetic CD40-/- model; functional readout in transplant model; single lab","pmids":["32149455"],"is_preprint":false}],"current_model":"CD11b (ITGAM) is the α-chain of the β2-integrin Mac-1/CR3 (CD11b/CD18), stored in neutrophil secondary (gelatinase-rich) granules and translocated to the cell surface upon activation; it functions as a multi-ligand adhesion and signaling receptor recognizing iC3b, ICAM-1, fibrinogen, GPIbα, FHA, oligodeoxynucleotides, beta-glucan, and CD154, mediating phagocytosis, cell adhesion, and migration; its activation state is regulated by redox-dependent S-thiolation via a tyrosine kinase pathway, by NO/GC/cGMP/PKG/CREB signaling, and by the S100A8/A9 alarmin; once activated (including by small molecule agonists such as LA1/ADH-503), CD11b suppresses TLR-dependent pro-inflammatory signaling through an AKT/FOXO3/IRF3/7 pathway, negatively regulates BCR signaling through direct CD22 binding and SHP-1 recruitment, counteracts Mincle/Syk-driven inflammation via a Lyn-SIRPα-SHP1 complex, prevents chondrocyte mineralization via suppression of IL-6, regulates the Treg/Th17 balance through DC-derived IL-6, and interacts mechanically with Piezo1 in macrophages; lupus-associated loss-of-function variants (notably R77H/rs1143679) impair phagocytosis, adhesion, and TLR suppression, linking reduced CD11b activity to SLE pathogenesis; the ITGAM/CD11b promoter is controlled by the GABP transcription factor and a minimal 242 bp myeloid-specific promoter element, and its expression is developmentally regulated during myeloid differentiation at the mRNA level."},"narrative":{"mechanistic_narrative":"ITGAM (CD11b) is the α-chain of the β2-integrin Mac-1/CR3 (CD11b/CD18), a myeloid multi-ligand adhesion and signaling receptor that couples leukocyte recognition of opsonized and microbial surfaces to phagocytosis, migration, and the tuning of inflammatory output [PMID:8485905, PMID:2153038]. As a promiscuous receptor it engages iC3b, ICAM-1, β-glucan, fibrinogen, oligodeoxynucleotides, the platelet receptor GPIbα, and bacterial adhesins, with ligand engagement driving phagocytosis and adhesion-dependent reactive oxygen production while constraining β2-dependent migration [PMID:8485905, PMID:9095175, PMID:19752320, PMID:16239529]. Its activation state is switched on by oxidative S-thiolation downstream of tyrosine kinase signaling and by NO–guanylate cyclase–cGMP–PKG–CREB signaling that upregulates surface CD11b [PMID:10556796, PMID:16551637]. Beyond adhesion, activated CD11b acts as a negative regulator of inflammation: it suppresses TLR-dependent inflammatory and type I interferon responses through an AKT/FOXO3/IRF3/IRF7 axis [PMID:28263189], dampens BCR signaling by directly binding CD22 to recruit SHP-1 and enforce autoreactive B cell tolerance [PMID:24264377], and restrains Mincle/Syk-driven macrophage inflammation by assembling a Lyn–SIRPα–SHP1 complex that dephosphorylates Syk [PMID:29400702]. Through these activities CD11b governs macrophage polarization (via Let-7a/cMyc) [PMID:30568188], the dendritic-cell IL-6–driven Treg/Th17 balance [PMID:28191643], and tissue inflammation in hypertensive vascular and cardiac remodeling [PMID:36377602, PMID:36822392]. Lupus-associated loss-of-function variants, notably R77H/rs1143679, impair phagocytosis, adhesion, and TLR/IFN-I suppression, mechanistically linking reduced CD11b activity to SLE pathogenesis [PMID:22586164, PMID:28263189], and small-molecule agonists (LA1, ADH-503) restore these regulatory functions in disease models [PMID:28263189, PMID:31270275]. The ITGAM promoter is directly activated by the GABP transcription factor through a myeloid-specific minimal element, and expression rises coordinately with myeloid differentiation at the mRNA level [PMID:1683702, PMID:2562920, PMID:26170143].","teleology":[{"year":1990,"claim":"Established the storage and mobilization logic of CD11b, showing it is held in neutrophil secondary granules and rapidly delivered to the surface on activation — explaining how CD11b function is regulated by translocation rather than synthesis.","evidence":"Subcellular fractionation and surface expression measurement before/after FMLP stimulation in neonatal vs adult neutrophils","pmids":["2153038"],"confidence":"High","gaps":["Did not define the trafficking machinery linking granule release to activation","Mechanism of the neonatal translocation defect not resolved"]},{"year":1991,"claim":"Localized myeloid-specific, developmentally regulated CD11b expression to a minimal 242 bp promoter, establishing transcriptional control of the gene during myelopoiesis.","evidence":"Promoter cloning, transcription start site mapping, and promoter-reporter assays in cell lines","pmids":["1683702"],"confidence":"Medium","gaps":["Did not identify the specific transcription factors binding the element","Endogenous chromatin context not tested"]},{"year":1993,"claim":"Defined CR3 as a multi-ligand adhesion and phagocytic/cytotoxicity receptor whose β-glucan engagement primes recognition of iC3b-coated targets, framing CD11b as a dual adhesion/effector receptor.","evidence":"Functional binding, phagocytosis and cytotoxicity assays with β-glucan and anti-CR3 antibodies","pmids":["8485905"],"confidence":"Medium","gaps":["Ligand-binding sites within CD11b not mapped","Signaling downstream of activated receptor not defined"]},{"year":1997,"claim":"Showed Mac-1 binds oligodeoxynucleotides at sites overlapping its fibrinogen ligand and couples this to functional outputs (inhibited migration, increased ROS), revealing that ligand occupancy redirects neutrophil behavior.","evidence":"Competitive binding, antibody blocking, Matrigel migration and ROS assays in PMNs","pmids":["9095175"],"confidence":"High","gaps":["Physiological relevance of ODN binding unclear","Structural basis of shared binding site not defined"]},{"year":1999,"claim":"Identified an oxidative S-thiolation mechanism downstream of tyrosine kinase signaling as the switch driving CD11b/CD18 activation, connecting redox state to integrin conformational activation.","evidence":"Neutrophil adhesion and activation-neoepitope (mAb 24) assays with kinase, sulfhydryl, and oxidase inhibitors","pmids":["10556796"],"confidence":"High","gaps":["Specific cysteine residues modified not identified","Link between thiolation and conformational change not structurally resolved"]},{"year":2005,"claim":"Demonstrated CR3 serves as the receptor for the Bordetella adhesin FHA and that ligand binding, not surface expression level, governs phagocytic signaling — separating receptor abundance from functional activation.","evidence":"Anti-CR3 blocking, bacterial mutant panel, and dissociation of expression from phagocytosis","pmids":["16239529"],"confidence":"High","gaps":["Signaling events triggering phagocytosis not dissected","How some toxins evade CR3-mediated uptake unresolved"]},{"year":2006,"claim":"Established a NO–guanylate cyclase–cGMP–PKG–CREB pathway as a transcriptional route to CD11b upregulation in microglia, identifying a second activation input distinct from redox/conformational switching.","evidence":"Pharmacological node-by-node dissection with NO donors/scavengers and GC/PKG inhibitors in microglia, plus in vivo microinjection","pmids":["16551637"],"confidence":"High","gaps":["CREB target sites in the ITGAM promoter not mapped","Generalizability beyond microglia not tested"]},{"year":2009,"claim":"Placed Mac-1 at the inflammation–thrombosis interface by showing its interaction with platelet GPIbα drives glomerular thrombosis, defining a specific molecular bridge between neutrophils and platelets.","evidence":"Mac-1-deficient mice, cell depletions, and antibody blockade of the Mac-1–GPIbα interaction in glomerulonephritis","pmids":["19752320"],"confidence":"High","gaps":["Structural basis of Mac-1–GPIbα binding not defined","Contribution relative to other Mac-1 ligands in thrombosis unclear"]},{"year":2012,"claim":"Provided the first mechanistic link between the lupus risk allele R77H/rs1143679 and CR3 dysfunction, showing the variant impairs phagocytosis, adhesion, and TLR suppression without altering expression.","evidence":"Functional assays in primary human monocytes from genotyped donors plus variant-specific transfection in COS7 cells","pmids":["22586164"],"confidence":"High","gaps":["Structural consequence of R77H on the receptor not resolved","Which downstream pathway loss dominates SLE risk not isolated"]},{"year":2013,"claim":"Revealed a non-adhesive, intracellular-signaling role: CD11b directly binds CD22 to recruit SHP-1 and restrain BCR signaling, with R77H abrogating this — explaining how loss of CD11b activity breaks autoreactive B cell tolerance.","evidence":"Co-IP of CD22-CD11b, BCR proliferation/phospho/calcium assays in CD11b-deficient B cells, variant rescue, and in vivo engagement","pmids":["24264377"],"confidence":"High","gaps":["Stoichiometry and structural interface of CD11b-CD22 binding not defined","How CD11b ligand engagement couples to CD22 recruitment unclear"]},{"year":2017,"claim":"Defined CD11b as a brake on TLR-driven inflammation and type I interferon via an AKT/FOXO3/IRF3/IRF7 axis, and showed pharmacological activation (LA1) reverses elevated IFN-I in lupus models and human SNP-carrier cells.","evidence":"LA1 agonist, CD11b-deficient and MRL/Lpr mice, pathway analysis, and macrophages from human ITGAM SNP carriers","pmids":["28263189"],"confidence":"High","gaps":["How integrin signaling engages AKT/FOXO3 mechanistically not fully resolved","Cell-type-specific contributions not delineated"]},{"year":2017,"claim":"Placed CD11b upstream of the IL-6/Th17 axis, showing CD11b-deficient dendritic cells overproduce IL-6 to skew the Treg/Th17 balance and worsen arthritis, rescuable by CD11b+ DC transfer or IL-6R blockade.","evidence":"CD11b-KO CIA arthritis model, DC–T cell co-culture, anti-IL-6R blockade, and adoptive transfer rescue","pmids":["28191643"],"confidence":"High","gaps":["Mechanism by which CD11b restrains DC IL-6 production not defined","Direct vs indirect effects on Treg not separated"]},{"year":2018,"claim":"Identified the molecular machinery of CD11b's inflammatory brake in macrophages — a Mincle-CD11b complex recruiting Lyn-SIRPα-SHP1 to dephosphorylate Syk — generalizing the negative-regulatory function to anti-microbial signaling.","evidence":"Co-IP of the Mincle-CD11b complex, CD11b-KO macrophages, Syk phospho assays, and Lyn activator in a mycobacterial model","pmids":["29400702"],"confidence":"High","gaps":["Order of assembly of the Lyn-SIRPα-SHP1 complex not resolved","Whether this complex operates outside Mincle signaling untested"]},{"year":2018,"claim":"Connected CD11b activation state to macrophage polarization through a Let-7a/cMyc switch, showing CD11b controls myeloid phenotype rather than recruitment and that agonism (LA1) suppresses tumor growth.","evidence":"CD11b KO and LA1 activation, Let-7a/cMyc expression analysis, and multiple tumor models","pmids":["30568188"],"confidence":"High","gaps":["How integrin signaling regulates Let-7a transcription unknown","Link between polarization switch and the AKT/FOXO3 pathway not integrated"]},{"year":2019,"claim":"Translated CD11b agonism to cancer immunotherapy, showing ADH-503 repolarizes tumor-associated macrophages and sensitizes resistant tumors to checkpoint blockade.","evidence":"ADH-503 agonist in murine PDAC models with flow cytometry and checkpoint inhibitor combination","pmids":["31270275"],"confidence":"Medium","gaps":["Molecular mechanism of repolarization not dissected","Off-target and dose-dependent effects of partial activation not defined"]},{"year":2019,"claim":"Defined the structural basis of CD11b's role as a toxin receptor, showing the staphylococcal leukocidin LukGH binds the CD11b α-I domain and that human CD11b drives the oligomerization required for cytolysis.","evidence":"Crystal structures of LukGH with human/murine CD11b-I, SAXS, engineered variants, and cytolysis assays","pmids":["31852826"],"confidence":"High","gaps":["Physiological consequence of LukGH-CD11b interaction in infection not quantified","Whether endogenous ligands use the same α-I interface unresolved"]},{"year":2020,"claim":"Extended CD11b's inflammatory role to cardiovascular disease, establishing that myeloid CD11b mediates macrophage adhesion/migration driving hypertension and vascular remodeling, with bidirectional pharmacological control.","evidence":"CD11b KO, bone marrow chimeras, neutralizing antibody and LA1 in Ang II/DOCA-salt hypertension models","pmids":["36377602"],"confidence":"High","gaps":["Endothelial ligand engaged during recruitment not identified","Reconciliation with anti-inflammatory roles of CD11b in other contexts unaddressed"]},{"year":2020,"claim":"Identified a chondroprotective function in which CD11b signaling suppresses IL-6-driven chondrocyte hypertrophy and mineralization, with deficiency worsening osteoarthritis.","evidence":"CD11b-KO chondrocytes, mineralization/Alp assays, anti-IL-6R blockade, LA1 agonist, and an in vivo meniscectomy OA model","pmids":["33392201"],"confidence":"High","gaps":["How CD11b is engaged on chondrocytes mechanistically unclear","Source of relevant CD11b ligand in cartilage not identified"]},{"year":2021,"claim":"Linked CD11b to mechanotransduction, showing reciprocal regulation with Piezo1 in stretch-responding macrophages and an actin-dependent role in mechanically driven inflammation.","evidence":"Static/cyclic stretch with reciprocal siRNA knockdown of CD11b and Piezo1 and actin polymerization inhibition","pmids":["34630381"],"confidence":"Medium","gaps":["Direct physical interaction with Piezo1 not demonstrated","Molecular basis of reciprocal expression regulation unknown"]},{"year":2023,"claim":"Extended hypertensive disease mechanism to the heart, showing CD11b drives macrophage infiltration and M1 polarization in cardiac remodeling, with consistent bidirectional pharmacological modulation.","evidence":"CD11b KO, bone marrow chimeras, antibody and LA1 in Ang II/DOCA-salt cardiac models, plus macrophage-cardiomyocyte co-cultures","pmids":["36822392"],"confidence":"High","gaps":["Paracrine mediators of cardiomyocyte enlargement not fully defined","Why agonism worsens cardiac/vascular disease but protects in lupus/arthritis not mechanistically reconciled"]},{"year":2023,"claim":"Expanded the CD11b interactome by identifying Siglec-15 as a sialoglycan-dependent binding partner on human T cells, suggesting a role in T-cell-directed immune regulation.","evidence":"Siglec-15 crystal structure, STD-NMR, molecular dynamics, and binding-partner identification on T cells","pmids":["37311743"],"confidence":"High","gaps":["Functional consequence of Siglec-15-CD11b binding not established","Whether interaction occurs in cis or trans not resolved"]},{"year":null,"claim":"It remains unresolved how the same receptor produces opposing disease outcomes — anti-inflammatory/protective in lupus, arthritis, and osteoarthritis but pathogenic in hypertensive cardiovascular remodeling — and what governs the choice between its adhesion/phagocytic and intracellular negative-regulatory programs.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking ligand identity to signaling outcome","Structural consequences of R77H and of agonist binding not resolved at atomic level","Cell-type-specific signaling logic not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,7,15,23]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[0,18,22]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[12,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,10,13]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[9,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,15,25]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,9,10,13,20]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[7,23,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,10,23,24]}],"complexes":["Mac-1/CR3 (CD11b/CD18)"],"partners":["ITGB2","CD22","GP1BA","SIRPA","LYN","CLEC4E","FOLR2","SIGLEC15"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P11215","full_name":"Integrin alpha-M","aliases":["CD11 antigen-like family member B","CR-3 alpha chain","Cell surface glycoprotein MAC-1 subunit alpha","Leukocyte adhesion receptor MO1","Neutrophil adherence receptor"],"length_aa":1152,"mass_kda":127.2,"function":"Integrin ITGAM/ITGB2 is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles and pathogens (PubMed:20008295, PubMed:9558116). It is identical with CR-3, the receptor for the iC3b fragment of the third complement component. It probably recognizes the R-G-D peptide in C3b. Integrin ITGAM/ITGB2 is also a receptor for fibrinogen and factor X. It recognizes P1 and P2 peptides of fibrinogen gamma chain. Regulates neutrophil migration (PubMed:28807980). In association with beta subunit ITGB2/CD18, required for CD177-PRTN3-mediated activation of TNF primed neutrophils (PubMed:21193407). Integrin ITGAM/ITGB2 is also a receptor for ICAM1 ligand ensuring adhesion between stimulated neutrophils and stimulated endothelial cells (PubMed:1980124). May regulate phagocytosis-induced apoptosis in extravasated neutrophils (By similarity). May play a role in mast cell development (By similarity). Required with TYROBP/DAP12 in microglia to control production of microglial superoxide ions which promote the neuronal apoptosis that occurs during brain development (By similarity)","subcellular_location":"Cell membrane; Membrane raft","url":"https://www.uniprot.org/uniprotkb/P11215/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ITGAM","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ITGAM","total_profiled":1310},"omim":[{"mim_id":"619558","title":"RAB39A, MEMBER RAS ONCOGENE FAMILY; RAB39A","url":"https://www.omim.org/entry/619558"},{"mim_id":"616626","title":"CEREBRAL ENDOTHELIAL CELL ADHESION MOLECULE; CERCAM","url":"https://www.omim.org/entry/616626"},{"mim_id":"616484","title":"TAX1-BINDING PROTEIN 3; TAX1BP3","url":"https://www.omim.org/entry/616484"},{"mim_id":"615747","title":"CEA CELL ADHESION MOLECULE 8; CEACAM8","url":"https://www.omim.org/entry/615747"},{"mim_id":"615746","title":"ZXD FAMILY ZINC FINGER PROTEIN C; ZXDC","url":"https://www.omim.org/entry/615746"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":172.8}],"url":"https://www.proteinatlas.org/search/ITGAM"},"hgnc":{"alias_symbol":["HNA-4","MAC-1","CD11b"],"prev_symbol":["CR3A","CD11B"]},"alphafold":{"accession":"P11215","domains":[{"cath_id":"2.130.10.130","chopping":"20-142_349-615","consensus_level":"medium","plddt":92.0702,"start":20,"end":615},{"cath_id":"3.40.50.410","chopping":"150-338","consensus_level":"high","plddt":90.2107,"start":150,"end":338},{"cath_id":"2.60.40.1460","chopping":"619-765","consensus_level":"high","plddt":86.6673,"start":619,"end":765},{"cath_id":"2.60.40.1510","chopping":"781-924","consensus_level":"high","plddt":82.0299,"start":781,"end":924},{"cath_id":"2.60.40.1530","chopping":"928-1100","consensus_level":"high","plddt":85.6078,"start":928,"end":1100}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11215","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11215-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11215-F1-predicted_aligned_error_v6.png","plddt_mean":86.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ITGAM","jax_strain_url":"https://www.jax.org/strain/search?query=ITGAM"},"sequence":{"accession":"P11215","fasta_url":"https://rest.uniprot.org/uniprotkb/P11215.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11215/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11215"}},"corpus_meta":[{"pmid":"23352232","id":"PMC_23352232","title":"Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen.","date":"2013","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23352232","citation_count":751,"is_preprint":false},{"pmid":"19346498","id":"PMC_19346498","title":"Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19346498","citation_count":356,"is_preprint":false},{"pmid":"17911608","id":"PMC_17911608","title":"CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17911608","citation_count":298,"is_preprint":false},{"pmid":"34800368","id":"PMC_34800368","title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/34800368","citation_count":291,"is_preprint":false},{"pmid":"8485905","id":"PMC_8485905","title":"CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions.","date":"1993","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8485905","citation_count":242,"is_preprint":false},{"pmid":"30568188","id":"PMC_30568188","title":"Integrin CD11b activation drives anti-tumor innate immunity.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30568188","citation_count":212,"is_preprint":false},{"pmid":"29196450","id":"PMC_29196450","title":"Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses.","date":"2017","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29196450","citation_count":203,"is_preprint":false},{"pmid":"9095175","id":"PMC_9095175","title":"Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein.","date":"1997","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9095175","citation_count":196,"is_preprint":false},{"pmid":"16551637","id":"PMC_16551637","title":"Up-regulation of microglial CD11b expression by nitric oxide.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16551637","citation_count":186,"is_preprint":false},{"pmid":"18762778","id":"PMC_18762778","title":"Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils.","date":"2008","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18762778","citation_count":183,"is_preprint":false},{"pmid":"26598697","id":"PMC_26598697","title":"CD11b+Ly6G- myeloid cells mediate mechanical inflammatory pain hypersensitivity.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26598697","citation_count":166,"is_preprint":false},{"pmid":"31270275","id":"PMC_31270275","title":"Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.","date":"2019","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31270275","citation_count":159,"is_preprint":false},{"pmid":"22110167","id":"PMC_22110167","title":"A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22110167","citation_count":142,"is_preprint":false},{"pmid":"2562920","id":"PMC_2562920","title":"Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation.","date":"1989","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2562920","citation_count":122,"is_preprint":false},{"pmid":"32134742","id":"PMC_32134742","title":"S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32134742","citation_count":118,"is_preprint":false},{"pmid":"26422753","id":"PMC_26422753","title":"CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs.","date":"2015","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26422753","citation_count":104,"is_preprint":false},{"pmid":"28931816","id":"PMC_28931816","title":"TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28931816","citation_count":90,"is_preprint":false},{"pmid":"1697310","id":"PMC_1697310","title":"IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1697310","citation_count":89,"is_preprint":false},{"pmid":"9038589","id":"PMC_9038589","title":"Neutrophil CD11B expression and neutrophil activation in pre-eclampsia.","date":"1997","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/9038589","citation_count":87,"is_preprint":false},{"pmid":"28263189","id":"PMC_28263189","title":"CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28263189","citation_count":87,"is_preprint":false},{"pmid":"7534806","id":"PMC_7534806","title":"Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures.","date":"1995","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/7534806","citation_count":84,"is_preprint":false},{"pmid":"34413303","id":"PMC_34413303","title":"CD11b+ lung dendritic cells at different stages of maturation induce Th17 or Th2 differentiation.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34413303","citation_count":83,"is_preprint":false},{"pmid":"22634719","id":"PMC_22634719","title":"Human \"orchestrator\" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity.","date":"2012","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/22634719","citation_count":82,"is_preprint":false},{"pmid":"18375763","id":"PMC_18375763","title":"CD11b expression distinguishes sequential stages of peritoneal B-1 development.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18375763","citation_count":81,"is_preprint":false},{"pmid":"29600248","id":"PMC_29600248","title":"CD11b Activity Modulates Pathogenesis of Lupus Nephritis.","date":"2018","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29600248","citation_count":75,"is_preprint":false},{"pmid":"8847330","id":"PMC_8847330","title":"Adaptation to eccentric exercise: effect on CD64 and CD11b/CD18 expression.","date":"1996","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/8847330","citation_count":75,"is_preprint":false},{"pmid":"19752320","id":"PMC_19752320","title":"Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.","date":"2009","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/19752320","citation_count":74,"is_preprint":false},{"pmid":"2153038","id":"PMC_2153038","title":"Subcellular distribution and mobilization of MAC-1 (CD11b/CD18) in neonatal neutrophils.","date":"1990","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2153038","citation_count":72,"is_preprint":false},{"pmid":"34630381","id":"PMC_34630381","title":"Crosstalk Between CD11b and Piezo1 Mediates Macrophage Responses to Mechanical Cues.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34630381","citation_count":67,"is_preprint":false},{"pmid":"22586164","id":"PMC_22586164","title":"The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes.","date":"2012","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22586164","citation_count":64,"is_preprint":false},{"pmid":"24264377","id":"PMC_24264377","title":"Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24264377","citation_count":63,"is_preprint":false},{"pmid":"1683702","id":"PMC_1683702","title":"The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1683702","citation_count":62,"is_preprint":false},{"pmid":"12009501","id":"PMC_12009501","title":"Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease.","date":"2002","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/12009501","citation_count":62,"is_preprint":false},{"pmid":"30531969","id":"PMC_30531969","title":"PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30531969","citation_count":60,"is_preprint":false},{"pmid":"26333171","id":"PMC_26333171","title":"Mouse CD11b+Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26333171","citation_count":60,"is_preprint":false},{"pmid":"23753600","id":"PMC_23753600","title":"The CD11b-integrin (ITGAM) and systemic lupus erythematosus.","date":"2013","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/23753600","citation_count":59,"is_preprint":false},{"pmid":"28423181","id":"PMC_28423181","title":"Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells.","date":"2017","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28423181","citation_count":56,"is_preprint":false},{"pmid":"32209471","id":"PMC_32209471","title":"SPHK2-Generated S1P in CD11b+ Macrophages Blocks STING to Suppress the Inflammatory Function of Alveolar Macrophages.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32209471","citation_count":54,"is_preprint":false},{"pmid":"1532218","id":"PMC_1532218","title":"Reduced expression of neutrophil CD11b and CD16 after severe traumatic injury.","date":"1992","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/1532218","citation_count":53,"is_preprint":false},{"pmid":"16239529","id":"PMC_16239529","title":"Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16239529","citation_count":52,"is_preprint":false},{"pmid":"26526388","id":"PMC_26526388","title":"CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26526388","citation_count":50,"is_preprint":false},{"pmid":"10556796","id":"PMC_10556796","title":"Redox regulation of beta2-integrin CD11b/CD18 activation.","date":"1999","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10556796","citation_count":50,"is_preprint":false},{"pmid":"34144215","id":"PMC_34144215","title":"Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34144215","citation_count":50,"is_preprint":false},{"pmid":"18496641","id":"PMC_18496641","title":"Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.","date":"2008","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/18496641","citation_count":49,"is_preprint":false},{"pmid":"11231849","id":"PMC_11231849","title":"Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production.","date":"2001","source":"Archives of surgery (Chicago, Ill. : 1960)","url":"https://pubmed.ncbi.nlm.nih.gov/11231849","citation_count":48,"is_preprint":false},{"pmid":"25854806","id":"PMC_25854806","title":"Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells.","date":"2015","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/25854806","citation_count":48,"is_preprint":false},{"pmid":"10329106","id":"PMC_10329106","title":"Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression.","date":"1999","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/10329106","citation_count":48,"is_preprint":false},{"pmid":"35026420","id":"PMC_35026420","title":"Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.","date":"2022","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/35026420","citation_count":45,"is_preprint":false},{"pmid":"36822392","id":"PMC_36822392","title":"CD11b mediates hypertensive cardiac remodeling by regulating macrophage infiltration and polarization.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/36822392","citation_count":43,"is_preprint":false},{"pmid":"37311743","id":"PMC_37311743","title":"Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37311743","citation_count":40,"is_preprint":false},{"pmid":"1980339","id":"PMC_1980339","title":"Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.","date":"1990","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1980339","citation_count":40,"is_preprint":false},{"pmid":"29973593","id":"PMC_29973593","title":"miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29973593","citation_count":39,"is_preprint":false},{"pmid":"15976367","id":"PMC_15976367","title":"Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives.","date":"2005","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/15976367","citation_count":37,"is_preprint":false},{"pmid":"35732342","id":"PMC_35732342","title":"CD11bhigh B Cells Increase after Stroke and Regulate Microglia.","date":"2022","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/35732342","citation_count":35,"is_preprint":false},{"pmid":"37934114","id":"PMC_37934114","title":"Nanozyme-Coated Bacteria Hitchhike on CD11b+ Immune Cells to Boost Tumor Radioimmunotherapy.","date":"2023","source":"Advanced materials (Deerfield Beach, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/37934114","citation_count":35,"is_preprint":false},{"pmid":"32149455","id":"PMC_32149455","title":"CD11b is a novel alternate receptor for CD154 during alloimmunity.","date":"2020","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/32149455","citation_count":34,"is_preprint":false},{"pmid":"28191643","id":"PMC_28191643","title":"CD11b regulates the Treg/Th17 balance in murine arthritis via IL-6.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28191643","citation_count":32,"is_preprint":false},{"pmid":"36377602","id":"PMC_36377602","title":"Integrin CD11b Contributes to Hypertension and Vascular Dysfunction Through Mediating Macrophage Adhesion and Migration.","date":"2022","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/36377602","citation_count":31,"is_preprint":false},{"pmid":"25548226","id":"PMC_25548226","title":"Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25548226","citation_count":31,"is_preprint":false},{"pmid":"26411420","id":"PMC_26411420","title":"Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.","date":"2015","source":"Clinical research in cardiology : official journal of the German Cardiac Society","url":"https://pubmed.ncbi.nlm.nih.gov/26411420","citation_count":30,"is_preprint":false},{"pmid":"27834952","id":"PMC_27834952","title":"Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway.","date":"2016","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27834952","citation_count":30,"is_preprint":false},{"pmid":"30413657","id":"PMC_30413657","title":"Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis.","date":"2018","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30413657","citation_count":30,"is_preprint":false},{"pmid":"24204843","id":"PMC_24204843","title":"Transcriptional reprogramming of CD11b+Esam(hi) dendritic cell identity and function by loss of Runx3.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24204843","citation_count":30,"is_preprint":false},{"pmid":"10779280","id":"PMC_10779280","title":"Expression of CD35 (CR1) and CD11b (CR3) on circulating neutrophils and eosinophils from allergic asthmatic children.","date":"1993","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10779280","citation_count":30,"is_preprint":false},{"pmid":"7586695","id":"PMC_7586695","title":"Investigation of the complement receptor 3 (CD11b/CD18) in human rectal epithelium.","date":"1995","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7586695","citation_count":29,"is_preprint":false},{"pmid":"29346347","id":"PMC_29346347","title":"CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin.","date":"2017","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29346347","citation_count":29,"is_preprint":false},{"pmid":"10837366","id":"PMC_10837366","title":"Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils: characterization and functional relevance.","date":"2000","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10837366","citation_count":28,"is_preprint":false},{"pmid":"26192732","id":"PMC_26192732","title":"CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice.","date":"2016","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26192732","citation_count":28,"is_preprint":false},{"pmid":"32780544","id":"PMC_32780544","title":"Immunosuppressive role of CD11b+ CD33+ HLA-DR- myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32780544","citation_count":27,"is_preprint":false},{"pmid":"29049725","id":"PMC_29049725","title":"CD11b and CD200 on Circulating Monocytes Differentiate Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/29049725","citation_count":27,"is_preprint":false},{"pmid":"31862674","id":"PMC_31862674","title":"Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells.","date":"2019","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31862674","citation_count":26,"is_preprint":false},{"pmid":"29374077","id":"PMC_29374077","title":"CD11b+ Dendritic Cell-Mediated Anti-Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29374077","citation_count":26,"is_preprint":false},{"pmid":"12452859","id":"PMC_12452859","title":"Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis.","date":"2002","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12452859","citation_count":26,"is_preprint":false},{"pmid":"31852826","id":"PMC_31852826","title":"Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31852826","citation_count":24,"is_preprint":false},{"pmid":"17286760","id":"PMC_17286760","title":"Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.","date":"2007","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17286760","citation_count":24,"is_preprint":false},{"pmid":"34804004","id":"PMC_34804004","title":"Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34804004","citation_count":23,"is_preprint":false},{"pmid":"30913515","id":"PMC_30913515","title":"Translocator protein localises to CD11b+ macrophages in atherosclerosis.","date":"2019","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/30913515","citation_count":23,"is_preprint":false},{"pmid":"22491252","id":"PMC_22491252","title":"Usp18 promotes conventional CD11b+ dendritic cell development.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22491252","citation_count":23,"is_preprint":false},{"pmid":"29400702","id":"PMC_29400702","title":"Integrin CD11b negatively regulates Mincle-induced signaling via the Lyn-SIRPα-SHP1 complex.","date":"2018","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29400702","citation_count":23,"is_preprint":false},{"pmid":"21931322","id":"PMC_21931322","title":"Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.","date":"2011","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/21931322","citation_count":23,"is_preprint":false},{"pmid":"33392201","id":"PMC_33392201","title":"CD11b Signaling Prevents Chondrocyte Mineralization and Attenuates the Severity of Osteoarthritis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33392201","citation_count":22,"is_preprint":false},{"pmid":"10722871","id":"PMC_10722871","title":"MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia.","date":"2000","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10722871","citation_count":22,"is_preprint":false},{"pmid":"28550361","id":"PMC_28550361","title":"Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.","date":"2017","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/28550361","citation_count":22,"is_preprint":false},{"pmid":"35288363","id":"PMC_35288363","title":"CD11b agonists offer a novel approach for treating lupus nephritis.","date":"2022","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35288363","citation_count":21,"is_preprint":false},{"pmid":"31072913","id":"PMC_31072913","title":"Prevention of lipopolysaccharide-induced CD11b+ immune cell infiltration in the kidney: role of AT2 receptors.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31072913","citation_count":21,"is_preprint":false},{"pmid":"27534550","id":"PMC_27534550","title":"Folate Receptor β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27534550","citation_count":21,"is_preprint":false},{"pmid":"10973693","id":"PMC_10973693","title":"Effect of isoproterenol and dexamethasone on the lipopolysaccharide induced expression of CD11b on bovine neutrophils.","date":"2000","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/10973693","citation_count":21,"is_preprint":false},{"pmid":"26065685","id":"PMC_26065685","title":"Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26065685","citation_count":21,"is_preprint":false},{"pmid":"26155126","id":"PMC_26155126","title":"Expression of CD11b and CD18 on polymorphonuclear neutrophils stimulated with interleukin-2.","date":"2014","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26155126","citation_count":20,"is_preprint":false},{"pmid":"25565310","id":"PMC_25565310","title":"CD11b is protective in complement-mediated immune complex glomerulonephritis.","date":"2015","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/25565310","citation_count":20,"is_preprint":false},{"pmid":"28110209","id":"PMC_28110209","title":"Expansion of CD11b+Ly-6C+ myeloid-derived suppressor cells (MDSCs) driven by galectin-9 attenuates CVB3-induced myocarditis.","date":"2017","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28110209","citation_count":20,"is_preprint":false},{"pmid":"30292636","id":"PMC_30292636","title":"mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b+Gr1+ cells.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30292636","citation_count":20,"is_preprint":false},{"pmid":"7618805","id":"PMC_7618805","title":"Down regulation of CD11b and CD18 expression in atherosclerotic lesion-derived macrophages.","date":"1995","source":"The American surgeon","url":"https://pubmed.ncbi.nlm.nih.gov/7618805","citation_count":18,"is_preprint":false},{"pmid":"28447995","id":"PMC_28447995","title":"Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility.","date":"2017","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/28447995","citation_count":18,"is_preprint":false},{"pmid":"30358484","id":"PMC_30358484","title":"Inducible Nitric Oxide Synthase and CD11b+Gr1+ Cells Impair Lymphatic Contraction of Tumor-Draining Lymphatic Vessels.","date":"2018","source":"Lymphatic research and biology","url":"https://pubmed.ncbi.nlm.nih.gov/30358484","citation_count":18,"is_preprint":false},{"pmid":"26170143","id":"PMC_26170143","title":"The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26170143","citation_count":17,"is_preprint":false},{"pmid":"29329880","id":"PMC_29329880","title":"Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.","date":"2018","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29329880","citation_count":17,"is_preprint":false},{"pmid":"7849290","id":"PMC_7849290","title":"Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7849290","citation_count":17,"is_preprint":false},{"pmid":"15550069","id":"PMC_15550069","title":"CD11b Expression on circulating leukocytes increases in preparation for parturition.","date":"2004","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/15550069","citation_count":17,"is_preprint":false},{"pmid":"32010784","id":"PMC_32010784","title":"Novel CD11b+Gr-1+Sca-1+ myeloid cells drive mortality in bacterial infection.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32010784","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51231,"output_tokens":8622,"usd":0.141512,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18692,"output_tokens":6617,"usd":0.129442,"stage2_stop_reason":"end_turn"},"total_usd":0.270954,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"CR3 (CD11b/CD18) functions both as an adhesion molecule and a phagocytic/cytotoxicity receptor with multiple ligand specificities, including iC3b, ICAM-1, bacterial carbohydrates/LPS, and soluble beta-glucan from yeast. Beta-glucan binding to CR3 induces an activated receptor state that permits neutrophil phagocytosis of iC3b-coated targets and NK cell cytotoxicity of iC3b-coated tumor cells that are normally resistant.\",\n      \"method\": \"Functional receptor binding assays, phagocytosis and cytotoxicity assays with beta-glucan and anti-CR3 antibodies\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays in a single review/research synthesis; replicated across phagocyte and NK cell contexts but methods described at abstract level\",\n      \"pmids\": [\"8485905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein; binding occurs on both the αM (CD11b) and β2 (CD18) subunits. Soluble fibrinogen (a natural Mac-1 ligand) competes with oligodeoxynucleotide binding. Upregulation of Mac-1 surface expression increases oligodeoxynucleotide binding and internalization by PMNs. Mac-1-bound oligodeoxynucleotides inhibit β2-dependent migration through Matrigel while dramatically increasing reactive oxygen species production in PMNs adherent to fibrinogen.\",\n      \"method\": \"Competitive binding assays with fibrinogen, anti-Mac-1 monoclonal antibody blocking, surface expression upregulation, Matrigel migration assay, ROS production assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (competitive binding, antibody blocking, functional migration and ROS assays) in a single focused study\",\n      \"pmids\": [\"9095175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Mac-1 (CD11b/CD18) is stored in gelatinase-rich (pre-gamma, secondary) granules of neutrophils and translocates to the plasma membrane upon chemotactic stimulation with FMLP. Neonatal neutrophils show diminished translocation of Mac-1 from these granular pools and reduced surface expression after FMLP stimulation, correlated with significantly lower gelatinase content, contributing to abnormal migratory properties.\",\n      \"method\": \"Subcellular fractionation, immunochemical assays, enzymatic gelatinase assays, surface expression measurement before and after FMLP stimulation comparing neonatal vs. adult neutrophils\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular fractionation with functional consequence (migration defect), multiple orthogonal biochemical methods\",\n      \"pmids\": [\"2153038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"The CD11b gene promoter region extending 242 bp upstream and 71 bp downstream of the transcription initiation site is sufficient to direct myeloid-specific and developmentally regulated expression in vitro, mimicking endogenous CD11b expression. A single transcription initiation site was identified, and the minimal promoter contains binding sites for transcription factors involved in hematopoietic-specific and phorbol ester-inducible gene expression.\",\n      \"method\": \"Promoter cloning, transcription start site mapping, promoter-reporter assays in cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter-reporter assay with defined minimal region, single lab\",\n      \"pmids\": [\"1683702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"CD11b/CD18 (Mo1) mRNA expression increases coordinately with cell surface protein expression during myeloid differentiation along both monocytic and granulocytic pathways in HL-60 cells, indicating regulation occurs at the mRNA level.\",\n      \"method\": \"Myeloid differentiation of HL-60 cells, mRNA quantification correlated with cell surface expression by flow cytometry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mRNA and protein expression correlated across two differentiation pathways, single lab\",\n      \"pmids\": [\"2562920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD11b/CD18 activation in neutrophils is regulated by an oxidative S-thiolation mechanism downstream of tyrosine kinase signaling. Exogenously added H2O2 induces CD11b/CD18-dependent adhesion and expression of an integrin activation neoepitope (mAb clone 24). This activation is inhibited by tyrosine kinase inhibitors and by complexing sulfhydryl groups with PAO. TNF-alpha-triggered CD11b/CD18 activation is blocked by the flavoprotein oxidoreductase inhibitor DPI and free radical scavengers.\",\n      \"method\": \"Neutrophil adhesion assays, integrin activation neoepitope detection (mAb 24), pharmacological inhibitors of tyrosine kinases, sulfhydryl reagents, oxidase inhibitors, and comparison with integrin-activating antibody (KIM 185)\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro assay with mechanistic inhibitor dissection using multiple orthogonal pharmacological tools and activation-state-specific antibody\",\n      \"pmids\": [\"10556796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Nitric oxide (NO) upregulates CD11b expression in microglial cells via the guanylate cyclase (GC)-cGMP-PKG-CREB signaling pathway. LPS-induced NO production increases CD11b expression; this is blocked by NO scavengers (PTIO) or iNOS inhibitors (L-NIL). The NO donor GSNO directly induces CD11b expression, and inhibitors of GC (NS2028) or PKG (KT5823, Rp-8-bromo-cGMP) block this upregulation, while 8-bromo-cGMP and cGMP phosphodiesterase inhibitor MY-5445 alone induce CD11b. GSNO-induced CREB activation via PKG was required.\",\n      \"method\": \"Pharmacological inhibitor/activator studies in BV-2 and primary microglial cells, NO donor treatment, in vivo co-microinjection experiments, flow cytometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple pharmacological pathway dissections with both inhibitors and activators at each node, in vitro and in vivo validation\",\n      \"pmids\": [\"16551637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mac-1 (CD11b/CD18) on recruited neutrophils is a critical molecular link between inflammation and thrombosis in glomerulonephritis. Mac-1-deficient mice show markedly attenuated neutrophil recruitment, endothelial injury, glomerular thrombosis, and acute renal failure. Neutrophil elastase activity is reduced in Mac-1-deficient mice, implicating it as an effector of Mac-1-mediated injury. Mac-1 on neutrophils interacts with glycoprotein Ibα (GPIbα) on platelets; antibody-mediated disruption of this Mac-1–GPIbα interaction attenuates thrombotic glomerulonephritis without affecting renal neutrophil accumulation.\",\n      \"method\": \"Genetic knockout (Mac-1-deficient mice), neutrophil immunodepletion, platelet immunodepletion, antibody-mediated blockade of Mac-1–GPIbα interaction, enzymatic activity assays, histopathology\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus specific antibody blockade of defined molecular interaction (Mac-1–GPIbα) with clear functional readout, multiple orthogonal approaches\",\n      \"pmids\": [\"19752320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The lupus-associated rs1143679 (R77H) variant of ITGAM (CD11b) impairs a broad range of CR3 effector functions in human monocytes, including: 31% reduction in phagocytosis of iC3b-opsonized erythrocytes, 24% reduction in adhesion to iC3b, and loss of CR3-ligation-mediated inhibition of TLR7/8-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α). The functional defect was confirmed by replication in COS7 cells transfected with variant-specific CD11b. No genotype-specific difference in CD11b expression or activation epitope expression was observed.\",\n      \"method\": \"Ex vivo monocytes/macrophages from homozygous WT or 77H donors; phagocytosis assay, adhesion assay, cytokine ELISA after CR3 ligation, conformation-specific antibody staining; COS7 cell transfection with variant-specific CD11b\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays in primary human cells plus independent validation in transfected cells; clear mechanistic separation of expression vs. function\",\n      \"pmids\": [\"22586164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD11b negatively regulates B cell receptor (BCR) signaling to maintain autoreactive B cell tolerance. CD11b-deficient autoreactive B cells show hyperproliferative BCR responses and enhanced survival. Mechanistically, CD11b directly binds CD22; in its absence, CD22-SHP-1 recruitment is diminished, leading to decreased Lyn and CD22 phosphorylation and increased calcium influx. The lupus-associated rs1143679 variant of CD11b completely abrogates this regulatory effect on BCR signaling through disruption of CD22-CD11b direct binding.\",\n      \"method\": \"Co-IP demonstrating CD22-CD11b direct binding, BCR crosslinking proliferation assay in CD11b-deficient vs. WT B cells, phosphotyrosine analysis, SHP-1 recruitment assay, calcium flux measurement, transfection of WT and rs1143679 variant CD11b, in vivo BCR engagement in CD11b-/- mice\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct binding shown by Co-IP, multiple orthogonal signaling assays, genetic KO, variant-specific functional rescue, in vivo validation\",\n      \"pmids\": [\"24264377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CD11b activation suppresses TLR-dependent inflammatory signaling and type I interferon (IFN-I) responses in leukocytes via an AKT/FOXO3/IRF3/IRF7 pathway. Pharmacological activation of CD11b with small molecule agonist LA1 reduces IFN-I responses in WT but not CD11b-deficient mice and protects lupus-prone MRL/Lpr mice from end-organ injury. Three nonsynonymous ITGAM SNPs that reduce CD11b activity are associated with elevated IFN-I in lupus patients. TLR-stimulated macrophages from CD11B SNP carriers show increased basal IRF7 and IFN-β expression and increased nuclear exclusion of FOXO3, all suppressed by LA1.\",\n      \"method\": \"Small molecule CD11b agonist (LA1) treatment, CD11b-deficient mice, lupus-prone mouse model (MRL/Lpr), signaling pathway analysis (AKT/FOXO3/IRF3/7), macrophages from human ITGAM SNP carriers, flow cytometry, ELISA\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological activation plus genetic KO controls, pathway dissection across multiple levels, validated in both mouse models and human primary cells from SNP carriers\",\n      \"pmids\": [\"28263189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD11b activation promotes pro-inflammatory (M1) macrophage polarization by stimulating expression of microRNA Let-7a. Conversely, CD11b inhibition prevents Let-7a expression and induces cMyc expression, leading to immune-suppressive macrophage polarization, vascular maturation, and accelerated tumor growth. Pharmacological activation of CD11b with small molecule agonist Leukadherin 1 (LA1) promotes pro-inflammatory polarization and suppresses tumor growth. Unexpectedly, CD11b does not regulate myeloid cell recruitment to tumors but controls myeloid cell polarization.\",\n      \"method\": \"CD11b genetic knockout and pharmacological activation (LA1), myeloid cell polarization assays, microRNA expression analysis (Let-7a), cMyc expression measurement, tumor growth models (murine and human cancer xenografts)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus pharmacological activation with defined molecular intermediates (Let-7a, cMyc), multiple cancer models, unexpected negative finding on recruitment rigorously established\",\n      \"pmids\": [\"30568188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The staphylococcal pore-forming cytotoxin leukocidin GH (LukGH) binds the α-I domain of CD11b with two binding interfaces (on LukG and LukH protomers). Human CD11b-I induces LukGH oligomerization in solution, which is required for cytolytic activity. LukGH binds murine CD11b-I weakly and is inactive toward murine neutrophils. A LukGH variant engineered to bind mouse CD11b-I demonstrated that cytolysis requires both binding and receptor-dependent oligomerization.\",\n      \"method\": \"Crystal structure of LukGH in complex with human and murine CD11b α-I domain, SAXS for oligomerization in solution, engineered LukGH variants with altered CD11b binding specificity, cytolysis assays with murine neutrophils\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus SAXS plus mutagenesis plus functional cytolysis assay; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"31852826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Integrin CD11b negatively regulates Mincle-mediated macrophage inflammatory signaling via recruitment of a Lyn-SIRPα-SHP1 complex. Upon Mincle activation by mycobacterial cord factor, CD11b is activated and forms a Mincle-CD11b signaling complex. Activated CD11b recruits Lyn, SIRPα, and SHP1, which dephosphorylate Syk to inhibit downstream Mincle-mediated inflammation. CD11b deficiency results in hyperinflammation following mycobacterial infection.\",\n      \"method\": \"Co-immunoprecipitation of Mincle-CD11b complex, CD11b knockout macrophages, phosphorylation assays for Syk, Lyn activator (MLR1023) experiments, mycobacterial infection model\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP defining complex components, genetic KO phenotype, pharmacological Lyn activator validating pathway, multiple orthogonal methods\",\n      \"pmids\": [\"29400702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The heteromeric transcription factor GABP (GABPα/GABPβ1) directly activates the ITGAM/CD11b promoter via three binding sites close to the translational start site, inducing CD11b expression and myeloid differentiation. Demonstrated by luciferase reporter assays, chromatin immunoprecipitation (ChIP), and Shield1-dependent proteotuning.\",\n      \"method\": \"Luciferase promoter reporter assays, chromatin immunoprecipitation (ChIP), Shield1-dependent protein-level tuning, surface marker and morphological analysis of myeloid differentiation, overexpression in U937 cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP plus reporter assay plus functional consequence (myeloid differentiation), three orthogonal methods, single lab\",\n      \"pmids\": [\"26170143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Folate receptor β (FRβ) interacts with CD11b/CD18 at the plasma membrane of macrophages, impairing CD11b/CD18-mediated adhesion to collagen. FRβ(+) macrophages and FRβ-transduced THP-1 cells show reduced adhesion to collagen compared to FRβ(-) counterparts. FRβ is only expressed by human macrophages differentiated with M-CSF.\",\n      \"method\": \"Affinity purification and mass spectrometric analysis of FRβ protein microenvironment, cell adhesion assay to collagen, FRβ transduction of THP-1 cells, flow cytometry, primary human macrophage differentiation conditions\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — affinity purification/MS for interaction plus functional adhesion assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"27534550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD11b signaling prevents chondrocyte hypertrophy and mineralization. CD11b-deficient chondrocytes show increased mineralization in vitro (quantified by Alizarin Red), elevated alkaline phosphatase (Alp) expression and activity, enhanced secretion of pro-mineralizing IL-6, and increased ratios of collagen X/collagen II and Runx2/Sox9 (indices of hypertrophy). Addition of anti-IL-6 receptor antibody to CD11b-KO chondrocytes reduces calcification, identifying IL-6 as a downstream mediator. CD11b agonist LA1 reduces chondrocyte mineralization, Alp expression, IL-6 production, and collagen X expression. In the meniscectomy OA model, CD11b deficiency leads to more severe OA.\",\n      \"method\": \"Primary murine CD11b KO chondrocytes, Alizarin Red staining for mineralization, qRT-PCR for gene expression, Alp activity assay, ELISA for IL-6, anti-IL-6R antibody blocking, CD11b agonist LA1, in vivo meniscectomy OA model with OARSI scoring\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus pharmacological rescue plus pathway blockade (anti-IL-6R) plus in vivo model; multiple orthogonal methods identifying IL-6 as mechanistic mediator\",\n      \"pmids\": [\"33392201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Siglec-15 binds integrin CD11b on human T cells as a binding partner. This interaction was identified by co-crystallization and binding studies; Siglec-15 binding to T cells (which lack STn expression) depends on α(2,3)- and α(2,6)-linked sialoglycans and requires CD11b as the receptor.\",\n      \"method\": \"Crystal structure of Siglec-15, STD-NMR spectroscopy for binding mode characterization, molecular dynamics simulations, identification of CD11b as Siglec-15 binding partner on T cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus NMR plus molecular dynamics plus functional binding partner identification; single study with multiple orthogonal structural/biophysical methods\",\n      \"pmids\": [\"37311743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CR3 (CD11b/CD18) serves as the receptor for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mediates phagocytosis of B. pertussis. FHA-mediated attachment to CR3 promotes phagocytosis. Anti-CR3 antibody blocks both attachment and phagocytosis. Elevated CR3 surface expression alone (induced by TNF-α, IFN-γ, FHA, or pertussis toxin) is not sufficient to promote phagocytosis; TNF-α increased both CR3 expression and phagocytic capacity, while IFN-γ increased expression without increasing phagocytosis. Adenylate cyclase toxin (ACT) resists phagocytosis independently of CR3 expression level.\",\n      \"method\": \"Anti-CR3 antibody blocking of attachment and phagocytosis, purified FHA/pertussis toxin/ACT treatments, CR3 surface expression measurement, phagocytosis assays with FHA mutants and SphB1 protease mutants\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antibody blockade plus bacterial mutant panel plus dissociation of expression vs. functional activation; mechanistic separation of ligand binding from phagocytic signaling\",\n      \"pmids\": [\"16239529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Partial pharmacological activation of CD11b with small molecule agonist ADH-503 repolarizes tumor-associated macrophages, reduces immunosuppressive myeloid cell infiltration in pancreatic tumors, and enhances dendritic cell and antitumor T cell responses, rendering checkpoint inhibitors effective in previously unresponsive PDAC models.\",\n      \"method\": \"Small molecule CD11b agonist (ADH-503) in mouse PDAC models, flow cytometry for myeloid cell polarization and T cell responses, combination with checkpoint inhibitors\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological activation with defined agent in multiple tumor models, but mechanism of polarization not fully dissected at molecular level in abstract\",\n      \"pmids\": [\"31270275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CD11b regulates the Treg/Th17 balance in murine arthritis via IL-6. CD11b-deficient dendritic cells produce much stronger IL-6 and induce enhanced Th17-cell differentiation compared to WT DCs. Anti-IL-6 receptor antibody treatment in CD11b-/- mice suppressed Th17 induction and reduced arthritis severity. Severe arthritis in CD11b-/- mice was rescued by adoptive transfer of CD11b+ DCs, placing CD11b upstream of IL-6-mediated Th17 differentiation.\",\n      \"method\": \"CD11b knockout mouse arthritis model (CIA), DC co-culture with T cells, IL-6 ELISA, anti-IL-6R antibody treatment, adoptive transfer of CD11b+ DCs\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus cytokine blockade plus adoptive transfer rescue; epistatic placement of CD11b upstream of IL-6/Th17 axis with multiple orthogonal approaches\",\n      \"pmids\": [\"28191643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"S100A8/A9 (alarmin) is required for upregulation of CD11b specifically on neutrophils during chronic tuberculosis infection, mediating neutrophil accumulation in the lung. S100A8/A9 deficiency results in reduced CD11b expression on neutrophils and impaired neutrophil accumulation, with improved Mycobacterium tuberculosis control during chronic (but not acute) TB.\",\n      \"method\": \"S100A8/A9-deficient mice, TB infection model, neutrophil depletion, flow cytometry for CD11b expression, comparison of acute vs. chronic TB\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic deficiency model with specific neutrophil CD11b phenotype; single lab, two orthogonal approaches (gene KO and neutrophil depletion)\",\n      \"pmids\": [\"32134742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CD11b is the major complement receptor mediating macrophage adherence to helminth larval surfaces. In vitro coculture of bone marrow-derived macrophages with H. polygyrus bakeri larvae demonstrated that CD11b mediates complement-dependent MΦ adherence. However, larval immobilization was largely independent of CD11b and instead required FcγRI (CD64).\",\n      \"method\": \"In vitro coculture assay of larvae and bone marrow-derived MΦ, CD11b-deficient macrophages, antibody blocking, in vivo challenge infection\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus in vitro assay plus in vivo validation; mechanistic distinction between adherence (CD11b) and immobilization (FcγRI) functions established\",\n      \"pmids\": [\"25548226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD11b on myeloid cells mediates macrophage adhesion and migration to the vasculature during hypertension. CD11b knockout or anti-CD11b antibody treatment attenuates Ang II-induced hypertension, aortic remodeling, superoxide generation, vascular dysfunction, and CD11b+ macrophage infiltration. Wild-type mice reconstituted with CD11b-deficient bone marrow recapitulate these protective effects. Conversely, CD11b agonist LA1 exacerbates hypertensive response.\",\n      \"method\": \"CD11b KO mice, bone marrow chimeras, pharmacological CD11b inhibition (neutralizing antibody) and activation (LA1), Ang II and DOCA-salt hypertension models, macrophage adhesion and migration assays in vitro, flow cytometry, aortic ring analysis\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus bone marrow chimera plus pharmacological bidirectional modulation (inhibition and activation); multiple orthogonal approaches in two hypertension models\",\n      \"pmids\": [\"36377602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD11b mediates hypertensive cardiac remodeling by regulating macrophage infiltration and M1 polarization. CD11b and CD18 are the most highly upregulated integrin subunits in Ang II-infused hearts. CD11b KO or neutralizing antibody treatment attenuates cardiac remodeling and macrophage infiltration/M1 polarization. CD11b agonist LA1 shows opposite (worsening) effects. In vitro, CD11b KO reduces macrophage adhesion and M1 polarization, and reduces paracrine-induced cardiomyocyte enlargement and fibroblast differentiation.\",\n      \"method\": \"CD11b KO mice, bone marrow chimeras, anti-CD11b antibody and LA1 agonist, Ang II and DOCA-salt cardiac remodeling models, in vitro macrophage-cardiomyocyte co-cultures, flow cytometry, histology\",\n      \"journal\": \"Journal of advanced research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus bone marrow chimera plus pharmacological bidirectional modulation in two disease models; in vitro mechanistic dissection of adhesion and polarization\",\n      \"pmids\": [\"36822392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CD11b and the mechanosensitive ion channel Piezo1 engage in crosstalk in macrophages responding to mechanical stretch. Both static and cyclic stretch increase CD11b expression and decrease Piezo1 expression. siRNA knockdown of CD11b abrogates stretch-mediated changes in inflammatory responses. Knockdown of CD11b enhances Piezo1 expression, and conversely knockdown of Piezo1 enhances CD11b expression, indicating reciprocal regulation. Stretch-mediated macrophage activation changes are dependent on actin polymerization.\",\n      \"method\": \"Static and cyclic uniaxial stretch apparatus, siRNA knockdown of CD11b and Piezo1, cytokine response assays (IFNγ/LPS and IL4/IL13 stimulation), actin polymerization inhibitor (pharmacological), flow cytometry for CD11b expression\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown of both interacting proteins with reciprocal phenotypes and functional readouts; single lab\",\n      \"pmids\": [\"34630381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CD154 (CD40L) can bind CD11b as an alternate receptor during alloimmunity, distinct from the classical CD154-CD40 interaction. A peptide antagonist that specifically blocks CD154-CD11b interaction (without affecting CD154-CD40) significantly increased allograft survival when combined with anti-CD40 antibody, and reduced graft-infiltrating CD8+ T cells and innate immune cells. CD154-CD11b antagonism was more effective than CD40 blockade alone.\",\n      \"method\": \"Fully allogeneic murine transplant model, CD40-/- hosts, CD154-CD11b-specific peptide antagonist, antibody blockade of CD40, flow cytometry for graft-infiltrating cells\",\n      \"journal\": \"American journal of transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific peptide antagonist for CD154-CD11b interaction (with CD40-independent controls) plus genetic CD40-/- model; functional readout in transplant model; single lab\",\n      \"pmids\": [\"32149455\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD11b (ITGAM) is the α-chain of the β2-integrin Mac-1/CR3 (CD11b/CD18), stored in neutrophil secondary (gelatinase-rich) granules and translocated to the cell surface upon activation; it functions as a multi-ligand adhesion and signaling receptor recognizing iC3b, ICAM-1, fibrinogen, GPIbα, FHA, oligodeoxynucleotides, beta-glucan, and CD154, mediating phagocytosis, cell adhesion, and migration; its activation state is regulated by redox-dependent S-thiolation via a tyrosine kinase pathway, by NO/GC/cGMP/PKG/CREB signaling, and by the S100A8/A9 alarmin; once activated (including by small molecule agonists such as LA1/ADH-503), CD11b suppresses TLR-dependent pro-inflammatory signaling through an AKT/FOXO3/IRF3/7 pathway, negatively regulates BCR signaling through direct CD22 binding and SHP-1 recruitment, counteracts Mincle/Syk-driven inflammation via a Lyn-SIRPα-SHP1 complex, prevents chondrocyte mineralization via suppression of IL-6, regulates the Treg/Th17 balance through DC-derived IL-6, and interacts mechanically with Piezo1 in macrophages; lupus-associated loss-of-function variants (notably R77H/rs1143679) impair phagocytosis, adhesion, and TLR suppression, linking reduced CD11b activity to SLE pathogenesis; the ITGAM/CD11b promoter is controlled by the GABP transcription factor and a minimal 242 bp myeloid-specific promoter element, and its expression is developmentally regulated during myeloid differentiation at the mRNA level.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ITGAM (CD11b) is the α-chain of the β2-integrin Mac-1/CR3 (CD11b/CD18), a myeloid multi-ligand adhesion and signaling receptor that couples leukocyte recognition of opsonized and microbial surfaces to phagocytosis, migration, and the tuning of inflammatory output [#0, #2]. As a promiscuous receptor it engages iC3b, ICAM-1, β-glucan, fibrinogen, oligodeoxynucleotides, the platelet receptor GPIbα, and bacterial adhesins, with ligand engagement driving phagocytosis and adhesion-dependent reactive oxygen production while constraining β2-dependent migration [#0, #1, #7, #18]. Its activation state is switched on by oxidative S-thiolation downstream of tyrosine kinase signaling and by NO–guanylate cyclase–cGMP–PKG–CREB signaling that upregulates surface CD11b [#5, #6]. Beyond adhesion, activated CD11b acts as a negative regulator of inflammation: it suppresses TLR-dependent inflammatory and type I interferon responses through an AKT/FOXO3/IRF3/IRF7 axis [#10], dampens BCR signaling by directly binding CD22 to recruit SHP-1 and enforce autoreactive B cell tolerance [#9], and restrains Mincle/Syk-driven macrophage inflammation by assembling a Lyn–SIRPα–SHP1 complex that dephosphorylates Syk [#13]. Through these activities CD11b governs macrophage polarization (via Let-7a/cMyc) [#11], the dendritic-cell IL-6–driven Treg/Th17 balance [#20], and tissue inflammation in hypertensive vascular and cardiac remodeling [#23, #24]. Lupus-associated loss-of-function variants, notably R77H/rs1143679, impair phagocytosis, adhesion, and TLR/IFN-I suppression, mechanistically linking reduced CD11b activity to SLE pathogenesis [#8, #10], and small-molecule agonists (LA1, ADH-503) restore these regulatory functions in disease models [#10, #19]. The ITGAM promoter is directly activated by the GABP transcription factor through a myeloid-specific minimal element, and expression rises coordinately with myeloid differentiation at the mRNA level [#3, #4, #14].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Established the storage and mobilization logic of CD11b, showing it is held in neutrophil secondary granules and rapidly delivered to the surface on activation — explaining how CD11b function is regulated by translocation rather than synthesis.\",\n      \"evidence\": \"Subcellular fractionation and surface expression measurement before/after FMLP stimulation in neonatal vs adult neutrophils\",\n      \"pmids\": [\"2153038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the trafficking machinery linking granule release to activation\", \"Mechanism of the neonatal translocation defect not resolved\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Localized myeloid-specific, developmentally regulated CD11b expression to a minimal 242 bp promoter, establishing transcriptional control of the gene during myelopoiesis.\",\n      \"evidence\": \"Promoter cloning, transcription start site mapping, and promoter-reporter assays in cell lines\",\n      \"pmids\": [\"1683702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the specific transcription factors binding the element\", \"Endogenous chromatin context not tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined CR3 as a multi-ligand adhesion and phagocytic/cytotoxicity receptor whose β-glucan engagement primes recognition of iC3b-coated targets, framing CD11b as a dual adhesion/effector receptor.\",\n      \"evidence\": \"Functional binding, phagocytosis and cytotoxicity assays with β-glucan and anti-CR3 antibodies\",\n      \"pmids\": [\"8485905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ligand-binding sites within CD11b not mapped\", \"Signaling downstream of activated receptor not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Showed Mac-1 binds oligodeoxynucleotides at sites overlapping its fibrinogen ligand and couples this to functional outputs (inhibited migration, increased ROS), revealing that ligand occupancy redirects neutrophil behavior.\",\n      \"evidence\": \"Competitive binding, antibody blocking, Matrigel migration and ROS assays in PMNs\",\n      \"pmids\": [\"9095175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of ODN binding unclear\", \"Structural basis of shared binding site not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified an oxidative S-thiolation mechanism downstream of tyrosine kinase signaling as the switch driving CD11b/CD18 activation, connecting redox state to integrin conformational activation.\",\n      \"evidence\": \"Neutrophil adhesion and activation-neoepitope (mAb 24) assays with kinase, sulfhydryl, and oxidase inhibitors\",\n      \"pmids\": [\"10556796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cysteine residues modified not identified\", \"Link between thiolation and conformational change not structurally resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated CR3 serves as the receptor for the Bordetella adhesin FHA and that ligand binding, not surface expression level, governs phagocytic signaling — separating receptor abundance from functional activation.\",\n      \"evidence\": \"Anti-CR3 blocking, bacterial mutant panel, and dissociation of expression from phagocytosis\",\n      \"pmids\": [\"16239529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling events triggering phagocytosis not dissected\", \"How some toxins evade CR3-mediated uptake unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established a NO–guanylate cyclase–cGMP–PKG–CREB pathway as a transcriptional route to CD11b upregulation in microglia, identifying a second activation input distinct from redox/conformational switching.\",\n      \"evidence\": \"Pharmacological node-by-node dissection with NO donors/scavengers and GC/PKG inhibitors in microglia, plus in vivo microinjection\",\n      \"pmids\": [\"16551637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CREB target sites in the ITGAM promoter not mapped\", \"Generalizability beyond microglia not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed Mac-1 at the inflammation–thrombosis interface by showing its interaction with platelet GPIbα drives glomerular thrombosis, defining a specific molecular bridge between neutrophils and platelets.\",\n      \"evidence\": \"Mac-1-deficient mice, cell depletions, and antibody blockade of the Mac-1–GPIbα interaction in glomerulonephritis\",\n      \"pmids\": [\"19752320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Mac-1–GPIbα binding not defined\", \"Contribution relative to other Mac-1 ligands in thrombosis unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided the first mechanistic link between the lupus risk allele R77H/rs1143679 and CR3 dysfunction, showing the variant impairs phagocytosis, adhesion, and TLR suppression without altering expression.\",\n      \"evidence\": \"Functional assays in primary human monocytes from genotyped donors plus variant-specific transfection in COS7 cells\",\n      \"pmids\": [\"22586164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural consequence of R77H on the receptor not resolved\", \"Which downstream pathway loss dominates SLE risk not isolated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed a non-adhesive, intracellular-signaling role: CD11b directly binds CD22 to recruit SHP-1 and restrain BCR signaling, with R77H abrogating this — explaining how loss of CD11b activity breaks autoreactive B cell tolerance.\",\n      \"evidence\": \"Co-IP of CD22-CD11b, BCR proliferation/phospho/calcium assays in CD11b-deficient B cells, variant rescue, and in vivo engagement\",\n      \"pmids\": [\"24264377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural interface of CD11b-CD22 binding not defined\", \"How CD11b ligand engagement couples to CD22 recruitment unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined CD11b as a brake on TLR-driven inflammation and type I interferon via an AKT/FOXO3/IRF3/IRF7 axis, and showed pharmacological activation (LA1) reverses elevated IFN-I in lupus models and human SNP-carrier cells.\",\n      \"evidence\": \"LA1 agonist, CD11b-deficient and MRL/Lpr mice, pathway analysis, and macrophages from human ITGAM SNP carriers\",\n      \"pmids\": [\"28263189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How integrin signaling engages AKT/FOXO3 mechanistically not fully resolved\", \"Cell-type-specific contributions not delineated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Placed CD11b upstream of the IL-6/Th17 axis, showing CD11b-deficient dendritic cells overproduce IL-6 to skew the Treg/Th17 balance and worsen arthritis, rescuable by CD11b+ DC transfer or IL-6R blockade.\",\n      \"evidence\": \"CD11b-KO CIA arthritis model, DC–T cell co-culture, anti-IL-6R blockade, and adoptive transfer rescue\",\n      \"pmids\": [\"28191643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which CD11b restrains DC IL-6 production not defined\", \"Direct vs indirect effects on Treg not separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified the molecular machinery of CD11b's inflammatory brake in macrophages — a Mincle-CD11b complex recruiting Lyn-SIRPα-SHP1 to dephosphorylate Syk — generalizing the negative-regulatory function to anti-microbial signaling.\",\n      \"evidence\": \"Co-IP of the Mincle-CD11b complex, CD11b-KO macrophages, Syk phospho assays, and Lyn activator in a mycobacterial model\",\n      \"pmids\": [\"29400702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of assembly of the Lyn-SIRPα-SHP1 complex not resolved\", \"Whether this complex operates outside Mincle signaling untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Connected CD11b activation state to macrophage polarization through a Let-7a/cMyc switch, showing CD11b controls myeloid phenotype rather than recruitment and that agonism (LA1) suppresses tumor growth.\",\n      \"evidence\": \"CD11b KO and LA1 activation, Let-7a/cMyc expression analysis, and multiple tumor models\",\n      \"pmids\": [\"30568188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How integrin signaling regulates Let-7a transcription unknown\", \"Link between polarization switch and the AKT/FOXO3 pathway not integrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Translated CD11b agonism to cancer immunotherapy, showing ADH-503 repolarizes tumor-associated macrophages and sensitizes resistant tumors to checkpoint blockade.\",\n      \"evidence\": \"ADH-503 agonist in murine PDAC models with flow cytometry and checkpoint inhibitor combination\",\n      \"pmids\": [\"31270275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of repolarization not dissected\", \"Off-target and dose-dependent effects of partial activation not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the structural basis of CD11b's role as a toxin receptor, showing the staphylococcal leukocidin LukGH binds the CD11b α-I domain and that human CD11b drives the oligomerization required for cytolysis.\",\n      \"evidence\": \"Crystal structures of LukGH with human/murine CD11b-I, SAXS, engineered variants, and cytolysis assays\",\n      \"pmids\": [\"31852826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequence of LukGH-CD11b interaction in infection not quantified\", \"Whether endogenous ligands use the same α-I interface unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extended CD11b's inflammatory role to cardiovascular disease, establishing that myeloid CD11b mediates macrophage adhesion/migration driving hypertension and vascular remodeling, with bidirectional pharmacological control.\",\n      \"evidence\": \"CD11b KO, bone marrow chimeras, neutralizing antibody and LA1 in Ang II/DOCA-salt hypertension models\",\n      \"pmids\": [\"36377602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial ligand engaged during recruitment not identified\", \"Reconciliation with anti-inflammatory roles of CD11b in other contexts unaddressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a chondroprotective function in which CD11b signaling suppresses IL-6-driven chondrocyte hypertrophy and mineralization, with deficiency worsening osteoarthritis.\",\n      \"evidence\": \"CD11b-KO chondrocytes, mineralization/Alp assays, anti-IL-6R blockade, LA1 agonist, and an in vivo meniscectomy OA model\",\n      \"pmids\": [\"33392201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CD11b is engaged on chondrocytes mechanistically unclear\", \"Source of relevant CD11b ligand in cartilage not identified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked CD11b to mechanotransduction, showing reciprocal regulation with Piezo1 in stretch-responding macrophages and an actin-dependent role in mechanically driven inflammation.\",\n      \"evidence\": \"Static/cyclic stretch with reciprocal siRNA knockdown of CD11b and Piezo1 and actin polymerization inhibition\",\n      \"pmids\": [\"34630381\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction with Piezo1 not demonstrated\", \"Molecular basis of reciprocal expression regulation unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended hypertensive disease mechanism to the heart, showing CD11b drives macrophage infiltration and M1 polarization in cardiac remodeling, with consistent bidirectional pharmacological modulation.\",\n      \"evidence\": \"CD11b KO, bone marrow chimeras, antibody and LA1 in Ang II/DOCA-salt cardiac models, plus macrophage-cardiomyocyte co-cultures\",\n      \"pmids\": [\"36822392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Paracrine mediators of cardiomyocyte enlargement not fully defined\", \"Why agonism worsens cardiac/vascular disease but protects in lupus/arthritis not mechanistically reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expanded the CD11b interactome by identifying Siglec-15 as a sialoglycan-dependent binding partner on human T cells, suggesting a role in T-cell-directed immune regulation.\",\n      \"evidence\": \"Siglec-15 crystal structure, STD-NMR, molecular dynamics, and binding-partner identification on T cells\",\n      \"pmids\": [\"37311743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Siglec-15-CD11b binding not established\", \"Whether interaction occurs in cis or trans not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the same receptor produces opposing disease outcomes — anti-inflammatory/protective in lupus, arthritis, and osteoarthritis but pathogenic in hypertensive cardiovascular remodeling — and what governs the choice between its adhesion/phagocytic and intracellular negative-regulatory programs.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking ligand identity to signaling outcome\", \"Structural consequences of R77H and of agonist binding not resolved at atomic level\", \"Cell-type-specific signaling logic not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 7, 15, 23]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [0, 18, 22]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [12, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 10, 13]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [9, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 15, 25]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 9, 10, 13, 20]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [7, 23, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 10, 23, 24]}\n    ],\n    \"complexes\": [\"Mac-1/CR3 (CD11b/CD18)\"],\n    \"partners\": [\"ITGB2\", \"CD22\", \"GP1BA\", \"SIRPA\", \"LYN\", \"CLEC4E\", \"FOLR2\", \"SIGLEC15\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}